Document

EX-10.1 2 idxx2024q310-qexhibit101.htm EX-10.1 Document

展覽10.1

第三次修訂和重訂

高管雇傭協議

本第三份修訂和重訂僱用協議（以下簡稱“本協議”）日期為2024年8月2日（以下簡稱“本日”），由特拉華州公司IDEXX Laboratories, Inc.（以下簡稱“公司”）和Jonathan（Jay）Mazelsky（以下簡稱“員工”）簽訂。協議生效日期權益代理31-Dec”) and amends and restates in its entirety the Second Amended and Restated Employment Agreement by and between the Company and the Executive dated as of October 23, 2019.

鑑於公司希望繼續聘用執行長擔任公司總裁兼首席執行官，並希望在下文條款和條件內明確獲得和確保執行長的服務；並

鑑於執行人希望繼續擔任公司的總裁兼首席執行官，並根據下文所述的條款和條件履行職務和為公司服務。

現在，基於本協議中包含的雙方契約和承諾，以及其他良好而有價值的考慮，本公司及執行長同意如下：

1.僱用期間公司特此同意繼續雇用高管，而高管特此同意在公司雇用下，都受本協議的條款和條件約束，於自生效日期開始，終至根據本協議，任何一方終止高管的僱用的日期。 3 為何Corcept Therapeutics股票今天飆升？僱用期間”).

2.僱傭條款.

(a)職位與職責; 獨家性.

(i)在僱用期間，執行將擔任公司總裁暨執行長，以及擔任公司及其相關公司（如下所定義）的其他職位，如執行和董事會董事會互相同意的，並將直接向董事會匯報。在執行擔任總裁暨執行長的職位時，執行應在僱用期間履行與此職位相當的職責、職能和責任，依董事會合理和合法的指示。在僱用期間，執行亦將擔任董事會成員。執行的主要工作地點將是公司的總部，目前位於緬因州的西布魯克。根據本協議所指，「董事會」一詞將包括任何由公司控制、受控或與公司共同控制的公司。董事會在僱用期間，執行將擔任公司總裁暨執行長，以及擔任公司及其相關公司（如下所定義）的其他職位，如執行和董事會董事會互相同意的，並將直接向董事會匯報。在執行擔任總裁暨執行長的職位時，執行應在僱用期間履行與此職位相當的職責、職能和責任，依董事會合理和合法的指示。在僱用期間，執行亦將擔任董事會成員。執行的主要工作地點將是公司的總部，目前位於緬因州的西布魯克。根據本協議所指，「董事會」一詞將包括任何由公司控制、受控或與公司共同控制的公司。附屬公司公司家族中的股份和等價項目在僱用期間，執行將擔任公司總裁暨執行長，以及擔任公司及其相關公司（如下所定義）的其他職位，如執行和董事會董事會互相同意的，並將直接向董事會匯報。在執行擔任總裁暨執行長的職位時，執行應在僱用期間履行與此職位相當的職責、職能和責任，依董事會合理和合法的指示。在僱用期間，執行亦將擔任董事會成員。執行的主要工作地點將是公司的總部，目前位於緬因州的西布魯克。根據本協議所指，「董事會」一詞將包括任何由公司控制、受控或與公司共同控制的公司。

(ii)在僱用期間內，執行長同意將幾乎全部業務時間和精力專注於所屬業務和事務

公司及其附屬公司，應忠實服務本公司，並遵守董事會向行政人員提供的合法和合理指示，並符合條款第二 (a) (i) 從這裡。在僱傭期間，行政人員應盡最大努力推廣及服務本公司的利益，不得從事任何其他業務活動，不得從事任何其他業務活動，無論該類活動是否以金錢利潤為目的；提供，行政人員可以 (A) 為任何公民、慈善、教育或專業組織服務，但該服務獲董事會主席及董事會管治及企業責任委員會主席批准（」企業及社會責任委員會」）、(B) 擔任一家非公司的非營利業務企業的董事會，提供該等服務獲董事會主席及商業委員會主席批准，並 (C) 管理行政人員的個人投資，只要任何該等活動不 (x) 違反本協議的條款（包括隨附的發明和保密協議的條款）展品 A 本條文及附加的禁止競爭協議如下附件 B 本條文）或 (y) 干擾行政人員對本公司的職責和責任。為此目的，」董事會主席」指董事會的首席獨立董事（如有），或董事會主席（如果他或她是獨立董事）。

(b)A類.

(i)基本薪金在僱用期間內，執行長的年薪為$1,150,000美元（“基本年薪”），按照公司的標準薪資政策支付。年度基本薪資在僱用期間內，基本年薪將於2025年日歷的第一季進行審查，之後至少每年審查一次。基本年薪的任何增加均不得用來限制或減少本合同中對執行長的其他義務。在任何此類增加之後，基本年薪不得降低，在本合同中使用的“基本年薪”一詞，指的是增加後的基本年薪。

(ii)年度獎金。除了按年度基本薪酬外，每個在僱傭期內結束的日曆年度，行政人員均有資格獲得年度獎金（年度獎金」) 根據董事會薪酬及人才委員會決定每個年度的公司績效及其他準則（」薪酬委員會」)。行政人員於生效日期至 2024 年 12 月開始的期間及其後僱傭期間結束的每個曆年度的目標年度獎金機會應等於該年度年底生效的年度基本薪酬的 125%（」目標年度獎勵機會」)。實際支付的年獎金額取決於薪酬委員會每年設定的績效目標的達到或超過程度，但目標年度獎金機會上限為 200%（除非薪酬委員會自行決定另有決定），並須受薪酬委員會決定的其他條款約束。年度獎金須於獲得該年獎金的日曆年度之後的三月十五日以現金支付；提供，行政人員必須於支付日期由本公司僱用，才能獲得年度獎金。


2

(iii)激勵計劃；基於股權的激勵獎勵在僱用期間，執行長將有資格參加公司的所有激勵計劃、慣例、政策和計畫（包括但不限於公司的2018年股票激勵計劃（“公司的任何後繼激勵計劃”）），程度與公司其他執行長適用的一般程度相同。2018年股權激勵計劃在僱用期間，執行長將有資格參加公司的所有激勵計劃、慣例、政策和計畫（包括但不限於公司的2018年股票激勵計劃（“公司的任何後繼激勵計劃”）），程度與公司其他執行長適用的一般程度相同。

(iv)福利待遇、儲蓄和養老計劃。在僱用期間內，執行人和/或執行人的家庭，如有適用情況，應有資格參與並受公司提供的福利待遇、儲蓄和養老計劃、慣例、政策和方案下的所有福利，這些福利通常適用於公司的其他執行官，並視情況不時生效。

(v)業務費用報銷在僱傭期間內，執行長有權依照公司不時生效的政策、做法和程序，就執行長因此產生的所有合理費用獲得退款。

(vi)PTO在僱用期間內，執行長將享有每年26天的有薪休假，根據公司不時生效的計劃、政策、計劃和做法。PTO

3.接受授予時，您承認、了解並同意以下所有內容：.

(a)死亡或殘疾。行政人員在僱傭期內死亡時，本行政人員在本條文下的僱傭將自動終止。如本公司誠意確定在僱傭期內發生行政殘疾（根據下文所述的殘疾定義），則可向行政人員提供書面通知，就其意終止行政人員的僱傭。在此情況下，行政人員在本公司的僱傭將於收到行政人員該通知後的 30 日起終止（」殘疾終止日期”); 提供，行政人員在收到該等事項後的 30 天內不得恢復全職履行行政職責。就本協議而言，」殘疾」指行政人員因醫療可判定的身體或精神障礙而無法從事任何重大的收益活動，可預期導致死亡或預期持續期不少於 12 個月，由本公司或其保險公司所選的醫生所決定，而且由行政人員或行政人員的法定代表合理接受的合理接受。

(b)為何Corcept Therapeutics股票今天飆升？。受第課程管轄 3(d)公司在僱用期間可以因原因或無原因而終止執行長的雇佣關係。根據本協議，「為何Corcept Therapeutics股票今天飆升？“以下情況”應當指以下情況之一：

(i)執行人在履行對公司的任務時故意行為失當或嚴重疏忽，如果可能


3

在執行經理收到董事會針對故意不當行為或重大過失發出書面通知後的30天內，若未能使董事會合理滿意，則不予以處治。

(ii)執行者故意不履行或拒絕合理指派給董事會的指示，或者不合作董事會內部調查，該調查由董事會進行或指示進行，如果能夠挽救，而未在執行者收到董事會書面通知該不履行或拒絕時30天內得到董事會合理滿意的根據，則無法被矯正；

(iii)對執行長提起任何公訴，執行長被判定任何罪名，或執行長承認有罪或無辯辭辯護 (x) 任何重罪或 (y) 涉及詐欺、偷竊、信任違反或類似行為的任何罪行（不論是否為重罪），無論在美國聯邦法律或任何州法律或執行長可能受其約束的任何外國法律下。

(iv)執行人刻意或持續不遵守公司的任何書面規則、法規、政策或程序，如果未遵守將合理地預期對公司的業務、財務狀況或聲譽產生重大不利影響，由公司合理酌情決定，對於可被紓解的失敗，未在執行人收到公司書面通知該等失敗後30天內為董事會合理滿意紓解的情況。

(v)高管濫用酒精或其他受控物質，可能合理預期會對公司的業務、財務狀況或聲譽產生重大不利影響，由公司以其合理判斷決定。

(c)合理理由。受第課程管轄 3(d)執行長在控制權變更期間（如下所定義）可以以正當理由終止執行長的僱傭，或在僱傭期間的任何時間（無論是否在控制權變更期間）不以正當理由終止。就本協議而言，“合理理由”即在控制權變更期間未經執行長同意而產生的以下一種或多種情況：

(i)執行長年度基本薪資或年度獎金機會的重大降低;

(ii)在執行的權限、職責或責任方面存在實質減少；提供為免疑問，如果（x）執行人員不再擔任公司總裁和首席執行官，任何業務合併生存的實體（如下所定義），或最終控制公司或此等生存實體的人員，或（y）如果執行人員需要向公司高級主管或員工匯報，而非直接向董事會匯報，那麼在每種情況下，執行的權限、職責或責任的實質減少將被視為發生。


4

(iii)行政留有權限的預算減少。

(iv)當執行人員必須從事服務的地理位置發生變化，導致執行人員單程通勤增加35英里以上；或

(v)其他任何行動或不作為，都構成公司對本協議的重大違約。

(d)終止通知。

(i)本公司可隨時在不少於 30 天的書面通知下終止行政人員在僱傭期內因原因以外，或因殘疾而終止行政人員的僱傭；行政人員可於僱傭期間內隨時不少於 60 天的書面通知，以任何原因終止該行政人員的僱傭。本公司可隨時因理由終止本行政人員的僱傭。任何由本公司（原因或原因以外的原因），或由行政人員因任何原因（包括理由）而終止，均須通過向本公司提供終止通知書予該對方進行終止通知。就本協議而言，a」通知終止」指書面通知書，其中 (A) 指出本協議中所依據的具體終止條文；(B) 在適用範圍內，在適用範圍內，以合理詳細列出聲稱為根據該條文終止行政人員僱傭的基礎的事實和情況，以及 (C) 如終止日期（如下所定義）不得超過該通知的日期，則指明終止日期（該日期不得超過三十天）在發出該等通知後）。如行政人員或公司未在終止通知中列出任何有助於證明有理由或理由的事實或情況（如適用），則不會分別放棄行政人員或本公司在本條文下的任何權利，或阻止行政人員或本公司分別在執行行政或本公司的權利時作出這些事實或情況。

(ii)在任何因故終止生效之前，執行官有權在董事會面前進行聽證，屆時他可以選擇由律師代表，並且應有合理的機會進行發言。該聽證會應至少提前15天書面通知執行官，告知董事會有意因故終止執行官，並詳細說明董事會認爲構成終止理由的特定事件或情況。

(iii)對於認為構成好的原因的控制項描述在第三節中的一個或多個條件，必須在60天之內向公司發出終止通知。 3（c）（i）到（v），執行者認為構成好的原因。若執行者向公司提供好的原因終止通知，公司應有30天的期間來改善所描述的控制項。


5

節 3(c)(i) 通過(v)導致所謂的充分理由。如果沒有這樣的補救措施，執行人員因充分理由終止僱傭關係將在此30天期限到期後的第二天生效。

(e)終止日期. “終止日期“意味着(i) 如果公司的原因終止高管的僱傭，終止通知的接收日期或公司指定的任何較晚日期，視具體情況而定；提供的，該日期可能會延遲以確保公司遵守第 3(d)(ii)；(ii) 如果高管因良好理由終止僱傭，前提是高管遵守第 3(d)(iii) 以及公司未能按第節規定進行補救， 3(d)(iii)，補救期到期日；（iii）如果高管因非正當理由終止僱傭關係，則在公司收到高管終止通知後的第60天，或者公司同意的任何更早或更晚的日期；（iv）如果高管因非故障或因殘疾或死亡而被公司終止僱傭關係，則在高管收到終止通知後的第30天，或公司指定的任何更晚日期；（v）如果高管因死亡或殘疾而終止僱傭關係，則終止日期應爲高管的死亡日期或殘疾終止日期，以實際情況爲準。

4.公司在終止時的義務.

(a)除因原因外. 如果在僱傭期內，公司終止執行官的僱傭關係而非因原因終止（除了因控制變更或在控制變更期間的終止（每項定義見下文），在每種情況下，須遵循第 5(c) 節）：

(i)公司應向執行人員一次性支付以下金額：包括（1）到終止日期之前未支付的執行人員年度基本工資；（2）按每個工作日年度基本工資標準支付的任何未使用的帶薪休假；（3）根據適用公司安排的相關條款支付的任何額外歸屬福利；以及（4）根據第條款支付的任何未報銷費用。 2(b)(v) （上述（1）、（2）、（3）和（4）中描述的金額總和以下稱爲“累積義務”); 且

(ii)在每種情況下，需遵循第12和第13節的規定， 11第12條和第13條條款以及執行人員繼續遵守附於本協議的發明與保密協議中規定的契約和義務。附錄 A與本協議附帶的競業禁止協議附件B公司應向執行人員提供：

A. 支付金額等於 (x) 2 的乘積，乘以 (y) 高管的年基本工資，在終止日期後的24個月期間按比例支付（“遣散期”);

b. 在執行者及時選擇根據1985年《綜合綜合預算調解法》（修正後）繼續覆蓋的情況下，COBRA一筆等於僱主部分成本的現金一次性支付


6

在終止日期時，根據適用的覆蓋水平，爲高管及其受保家屬提供持續的健康福利（“健康福利支付”）爲終止日期後24個月的時期提供；但是，如果公司根據本節提供給高管的健康福利支付 4(a)(i)（B）違反了適用於健康計劃或根據《美國法典》第105(h)條的自保計劃的不歧視規則，或導致根據2010年《患者保護與平價醫療法案》（「PPACA」）及其下頒佈的相關法規和指導方針施加罰款，雙方同意以符合PPACA和《美國法典》的方式修改本節 4(a)(i)（B），進一步提供的內容不得解釋爲延長根據適用法律向您和/或您的受扶養人提供COBRA延續覆蓋的時間。

C. 爲了任何授予執行官的股權激勵獎勵的目的，這些獎勵在終止日期仍然有效，儘管與適用的獎勵協議、2018年股票激勵計劃（或任何前身或後續的股權補償計劃）或其它地方的規定相反，這些本應在離職期間內到期的股權激勵獎勵將在離職期間繼續按照終止日期之前的歸屬時間表進行歸屬。此外，(i) 在終止日期前立即歸屬的任何期權可在終止日期後的90天內行使，或在終止日期時執行官符合「養老」資格（根據適用的期權獎勵協議定義）時，在終止日期後的24個月內行使（或，如果更長，則按適用的期權獎勵協議規定的行使期限），以及(ii) 根據上述句子在離職期間歸屬的任何期權可在離職期間結束後的90天內行使（或，如果更長，則按適用的期權獎勵協議規定的行使期限）。

(b)去世. 如果因執行人員在僱傭期間去世而終止執行人員的僱傭關係，則本協議將終止，除非向執行人員的法定代表提供進一步的義務，其他費用應根據適用情況以現金一次性支付給執行人員的遺產或受益人，並在終止日期後的30天內完成。

(c)殘疾如果因執行人員在僱傭期間的殘疾而終止其僱傭關係，本協議將終止，而對執行人員不再有其他義務，除非在終止日期後的30天內以一次性現金支付給執行人員應付的款項。

(d)原因；除了有正當理由。如果公司在僱用期內因故終止高管的聘用，則本協議應終止，除了向高管支付應計債務的義務外，不對高管承擔其他義務。如果高管在僱用期內自願終止僱用，不包括在控制權變更期間出於正當理由解僱，則本協議終止時除向行政部門支付應計債務的義務外，不對高管承擔進一步的義務。在這種情況下，所有應計債務應在終止之日起30天內以現金一次性支付給高管。


7

(e)支付時間根據本節的規定，應支付的金額。 4 在高管終止僱傭關係後，除非是明確規定的遞延支付款項，將在終止僱傭關係發生後的下一個發薪期支付，除非在第或 13節中另有規定。 11 或第13節。

5.控制項的變更.

(a)“控制項的變更“將在公司的2018年股票激勵計劃中被賦予該術語的含義，該計劃不時進行修訂或重新修訂。儘管有前述規定，任何在此處的支付或福利都應受1986年內部收入法典第409A節的限制（“代碼），控股變更必須構成財政部法規第1.409A-3(i)(5)(i)條款意義上的「控股變更事件」。

(b)控制權變更時對股權的處理.

(i)基於時間的獎勵儘管適用的獎勵協議、2018年股票激勵計劃（或任何前身或繼任的股權補償計劃）或其他地方有任何相反的規定，在控制權變更的完成之前，執行官持有的公司內每個當時未歸屬的基於股權的激勵獎勵（僅受基於時間的歸屬條件的限制）（每個稱爲“基於時間的獎勵”將立即歸屬（並在適用的情況下完全可行使）關於該基於股權的激勵獎勵所涵蓋的公司普通股的25%（向下取整爲最接近的整數股）（這些股份稱爲“加速股份”），每個基於時間的獎勵在執行官適用的獎勵協議中規定的每個歸屬日期應按比例減少可行使、歸屬、可實現、可交付且無限制的股份數量，減少的股份數量爲加速股份。

(ii)基於績效的獎勵. 儘管本文中有任何相反的規定，執行官所持有的每項仍未到期的公司的普通股票獎勵，包括但不限於任何股票期權、股票增值權、限制性股票單位獎勵、限制性股票獎勵或其他基於股票的獎勵，必須遵循該基於績效的獎勵在發生控制權變更時所規定的獎勵協議條款和條件。基於績效的獎勵）將受限於在控制權變更發生時所規定的該基於績效的獎勵協議的條款和條件。

(c)公司在因正當理由或其他原因終止後的義務在變更控制期間除因原因外如果公司因非原因終止執行官的僱傭，或者執行官因正當理由終止他的僱傭，均在變更控制發生時或在變更控制發生後24個月內（“控制權變更期間”):

(i)公司應支付執行官已到期的義務

一次性付款；以及

(ii)在每種情況下，需遵循第12和第13節的規定， 11, 公司


8

應向執行官提供一筆現金一次性支付，包括：

A.金額等於（x）三的乘積，乘以（y）年基本工資的總和，加上（ii）年度平均獎金。「年度平均獎金」應等於在過去3個完整日曆年內支付（或應支付）給高管的年度獎金的平均值（或者，如果更少，則爲高管在終止日期前在公司的完整日曆年數）；前提是如果高管在就業期間至少沒有資格獲得1個完整日曆年的年度獎金，則年度平均獎金應爲高管在終止就業的年度的目標年度獎金；

b. 健康福利支付，以覆蓋終止日期後36個月期間僱主部分的費用；前提是，如果公司根據本節向高管提供健康福利支付時， 5(c)(ii)(B) 將違反適用於健康計劃或根據《稅法》第105(h)條款的自保計劃的無歧視規則，或導致根據PPACA施加罰款，雙方同意改寫本節 5(c)(ii)(B) 以符合PPACA和《稅法》的方式；提供的, 進一步但本協議的任何內容不得被解釋爲延長根據適用法律提供給您和/或您的家屬的COBRA延續覆蓋的時間。

C. 儘管適用的獎勵協議、2018年股票激勵計劃（或任何前身或後繼股權補償計劃）或其他地方有相反規定，但公司中由高管持有的所有未歸屬的按時間計算的獎勵將立即歸屬（並全額可行使，視情況而定）；以及

D. 公司應及時向執行官報銷每年高達12,500美元（總計25,000美元）與外部安置服務和因在緬因州以外獲得新工作而產生的搬遷費用相關的支出，直到以下時間中的較早者：(i) 執行官就業終止後的24個月；或 (ii) 執行官獲得全職工作之日。

(d)支付時間根據第節應支付的金額 5(c) 在執行人員終止僱傭後，將在終止僱傭發生的下一工資期內支付，除非在第 11、12或13節中另有規定。

6.所有板塊辭職. 一旦公司與高管的僱傭關係因任何原因終止，如果董事會在其唯一裁量權內決定要求高管辭去其作爲公司董事的職務並不再以此身份任職，高管應迅速提交辭去公司董事職務的書面辭職信。如果高管未能及時提交辭職信，則應視爲自終止日期起自動辭職。此外，在高管與公司的僱傭關係因任何原因終止後，除非上述有明確規定，高管應自終止日期起辭去所有當時擔任的職務。


9

擔任公司及其子公司和附屬公司的官員、董事、員工和董事會（及其任何委員會）的成員。執行官應根據公司的獨立裁量權執行所需的書面文件，以實現上述目的。

7.權利的非獨佔性本協議中的任何內容均不應阻止或限制執行官持續或未來參與公司或其附屬公司提供的任何計劃、項目、政策或實踐，並且執行官可能符合資格。此外，根據第13(f)條的規定，本協議中的任何內容不應限制或以其他方式影響執行官在與公司或其附屬公司的任何合同或協議下的權利。在終止日期時或之後，根據公司或其附屬公司的任何計劃、政策、實踐或程序，或與公司或其附屬公司的任何合同或協議所應得的已歸屬權益或執行官其他應得的款項，均應根據該計劃、政策、實踐、程序或合同或協議支付，除非本協議明確修改。

8.完全結算。在由於控制變更或在控制變更期間（除了由於公司的過失導致的終止）而終止執行官的僱傭關係時，公司依據本協議應支付的款項和其他義務的履行不應受到任何抵消、反訴、追索、軍工股或其他索賠、權利或行動的影響，無論公司是否對執行官（根據本協議或其他）或其他任何人有上述權利。無論執行官終止僱傭關係的理由或時間如何（無論是在控制變更之前，還是在控制變更期間或之後），執行官均不應有義務尋求其他就業或採取任何其他可以減少根據本協議支付給執行官的金額的行動，除非本協議另有規定，這些金額無論執行官是否獲得其他就業均不會減少。

9.機密信息；限制性約定.

(a)執行者應以信託身份持有與公司或其任何關聯公司及其各自業務相關的所有祕密或機密信息、知識或數據，這些信息在執行者爲公司或其任何關聯公司工作期間獲得，並且這些信息不應成爲公衆知識（除非是由於執行者或執行者代表違反本協議的行爲）(機密信息）在執行者與公司的僱傭關係終止後，未經公司事先書面同意或法律或法律程序的要求，執行者不得向公司以外的任何人傳達或披露任何此類信息、知識或數據。執行者同意，本節的任何違反 9 或本協議附帶的發明與保密協議附錄 A與本協議附帶的競業禁止協議附件B 將導致公司遭受不可彌補的損害，而公司又無法在法律上獲得充分的救濟。因此，執行者還同意，在上述違約或任何違約威脅發生時，公司有權立即獲得禁令和限制令，以防止執行者及/或代表執行者的任何人違反和/或威脅違反及/或持續違反，無需證明


10

除了公司依法或按衡平法可享有的其他救濟之外，包括但不限於，執行人必須退還公司支付給執行人的離職支付及福利中規定的任何部分的義務。 4(a)(ii) 或 5(c)(ii)適用的，執行人所獲得的離職支付及福利由公司支付。本節的條款不應阻止公司因任何違反或威脅違反本條款而尋求任何其他可用的救濟，包括但不限於向執行人追索損害賠償。 9(a) 執行人和公司進一步同意，本節中蘊含的契約條款，以及附於本協議作爲附件A的發明和保密協議，以及附於本協議作爲附件B的競爭禁止協議，在各自情況下，都是合理且必要的，以保護公司及其附屬公司的業務，因爲執行人接觸了機密信息並且對該等業務有實質性的參與。 9

(b)公司與執行官承認執行官是之前簽署的發明和保密協議的當事方，該協議附在此處，展品 A以及競爭禁止協議，該協議附在此處，附件B該協議由公司與執行官之間簽署。

(c)自生效日期之後，包括在終止日期後的所有時間，(i) 高管同意不發表任何意圖成爲公衆聲明的意見，或合理預期將成爲公衆聲明的意見，且該意見批評、嘲笑、貶低或以其他方式貶損公司及其任何附屬公司，或其各自的員工、管理人員、董事或股東，(ii) 公司應指示其管理人員、董事和其他授權代表不發表任何意圖成爲公衆聲明的意見，或合理預期將成爲公衆聲明的意見，且該意見批評、嘲笑、貶低或以其他方式貶損高管。

(d) 此協議、附帶的發明與保密協議，以及附錄 A附帶的競業禁止協議，附件B 或公司的任何政策或程序，不應被解釋爲阻止根據適用法律或法規所要求或允許的機密信息披露；特別是涉及聯邦或州的行政機構（例如，，平等就業機會委員會，相應的州就業機構，證券交易委員會，等）幷包括作爲向該聯邦或州行政機構提交指控或投訴的一部分，或根據具有管轄權的法院或授權政府機構的有效命令進行的披露，前提是披露的程度不超過法律、法規或命令要求或允許的範圍。高管在向聯邦或州行政機構提起指控或投訴，或以其他方式參與可能由聯邦或州行政機構啓動的調查或程序時，不需要公司任何代表的事先授權或通知。具體而言，關於有管轄權的法院的命令，高管應立即向公司的總法律顧問提供任何此類命令的書面通知。如果公司選擇尋求保護性命令或其他救濟，高管將全力配合公司。如果公司未獲得保護性命令或其他


11

如果需要補救或放棄遵守本協議的某些條款，執行者將僅提供法律意見書中所需披露的保密信息部分，並將盡最大努力確保對此類披露的保密信息給予保密處理。此外，本協議中的任何內容都不以任何方式禁止或者旨在限制或妨礙，也不應被解釋或理解爲限制或妨礙執行者根據《國家勞動關係法》第7條行使權利，或者根據法律允許的方式披露信息。本協議中的任何內容都不以任何方式禁止或旨在限制或妨礙執行者根據任何受保護的舉報人或類似程序提供的信息，獲得任何聯邦或州行政機構的獎勵。

10.繼任者.

(a)本協議是針對執行者個人的，未經公司的事先書面同意，執行者不得以遺囑或繼承和分配法律以外的方式轉讓本協議。本協議應使執行者的法定代表人受益並具有可執行性。

(b)本協議將有利於公司及其繼任者和受讓人，並對其具有約束力。

(c)公司將要求任何繼承人（無論是直接或間接，通過購買、合併、整合或其他方式）承擔對公司所有或幾乎所有的業務和/或資產明確並同意以與公司在沒有發生此類繼承的情況下所要求的相同方式和相同程度執行本協議。在本協議中使用的“公司”應指上述定義的公司及其業務和/或資產的任何繼承人。

11.第409A條.

(a)本協議旨在遵守《稅法》第409A條及其下頒佈的規定（“第409A條”）或其下的豁免，並應根據第409A條進行解釋和管理。儘管本協議中的任何其他條款，本協議下提供的支付僅可以在符合第409A條或者適用的豁免的事件和方式下進行。根據第409A條，任何可能因自願解除服務而作爲分離支付或作爲開空延期而被排除在第409A條之外的支付，應在可能的最大程度上排除在第409A條之外。根據第409A條，本協議下提供的每一項分期付款應被視爲單獨的付款。根據本協議，因終止僱傭而應進行的任何付款，只有在符合第409A條下的「服務分離」後才能進行。儘管如此，公司不對本協議下提供的支付和福利符合第409A條的情況作出任何聲明，且公司在任何情況下不對因不符合第409A條而可能導致的執行人任何部分的稅款、罰款、利息或其他費用承擔責任。


12

(b)儘管本協議的其他條款另有規定，但如果任何支付或福利被認爲是在與高管終止僱傭關係相關的情況下構成「非合格遞延補償」，根據第409A條的定義，同時高管被確定爲第409A條所定義的「指定員工」，那麼該支付或福利將在終止日期後的六個月內的第一個工資發放日或在高管去世時（較早者）支付（“指定員工支付日期”）。在指定員工支付日期之前，任何本來應該支付的款項將一次性支付給高管，之後，任何剩餘款項應按照其原定計劃無延遲支付。

(c)根據第409A條的要求，根據本協議提供的每項報銷或實物福利應遵循以下規定：(i) 每個日曆年可報銷的費用或提供的實物福利的金額不能影響其他日曆年可報銷的費用或提供的實物福利；(ii) 任何符合條件的費用報銷應在費用發生的日曆年的最後一天之前支付給執行官；(iii) 根據本協議的任何報銷或實物福利的權利不應被清算或兌換爲其他福利。

12.第280G條. 行政人員特此同意所述條款展覽D 對本協議適用。

13.發佈. 作爲獲得本協議第節中規定的遣散費和福利的控件，執行官（或在因死亡或殘疾終止執行官的情況下，執行官的遺產、受益人或其他代表，視情況而定）將被要求籤署一份基本形式的索賠解除聲明，如附在此處的 4(a)(ii) 或 5(c)(ii) 展覽C (（"發佈”) and to abide by the provisions thereof. The Release contains a release and waiver of any claims the Executive or the Executive’s estate, beneficiaries and other representatives may have against the Company, any of its Affiliated Companies, and any of their respective officers, directors, affiliates and/or representatives, and shall release those entities and persons from any liability for such claims including, but not limited to, all employment discrimination claims. Except as otherwise provided in Section 11, payments and benefits under this Agreement will be paid on the 60th day following the Executive’s termination of employment provided the Executive has executed and submitted the Release and the statutory period during which the Executive is entitled to revoke the Release has expired on or before that 60th day without the Executive revoking the Release. Notwithstanding anything to the contrary herein, if the Executive fails to timely execute and submit the Release, or the Executive or revokes the Release after its timely execution and submission, the Executive will not be entitled to receive any of the severance payments or benefits, the receipt of which is made contingent upon such execution and non-revocation, as set forth in Sections 4(a)(ii) 和 5(c)(ii) hereof, as applicable.

14.Miscellaneous.


13

(a)本協議應受緬因州法律的管轄，並按其解釋，不考慮法律衝突原則。本協議的標題不屬於本協議的條款部分，且不具有任何效力。

(b)本協議不得以條款或條件的方式進行修訂或修改，除非由雙方或其各自的繼承者和法律代表簽署的書面協議。

(c)所有通知和其他通信應以書面形式進行，且應通過手遞、掛號或提供回執的郵件發送給另一方。


14

請求，預付郵資，或通過電子郵件，要求回執，地址如下（或由雙方通過類似通知指定的其他地址）：

如果是給執行官:

在公司記錄中文件上的地址和電子郵件。如果是給公司的：

IDEXX實驗室公司美國緬因州韋斯特布魯克市IDEXX驅動器一號注意：法律顧問

電子郵件：GeneralCounsel@idexx.com

通知和通信在實際被收件人收到時生效。

(d)本協議任何條款的無效或不可執行，不得影響本協議其他條款的有效性或可執行性。

(e)公司可能會根據適用的法律或法規，從本協議下應支付的任何款項中扣留聯邦、州、地方或外國稅款。

(f)執行人或公司未能要求嚴格遵守本協議的任何條款，或未能主張執行人或公司在本協議下可能擁有的任何權利，包括但不限於根據本協議第的善意解僱權，不應被視爲放棄該條款或權利或本協議的任何其他條款或權利。 3(c) 本協議的該條款不應視爲放棄該條款或權利或本協議的任何其他條款或權利。

(g)執行官與公司確認，除非在執行官與公司之間的其他書面協議中另有規定，執行官在公司的就業是「隨時可解僱」的，執行官的就業和/或本協議可以由執行官或公司隨時書面通知對方終止，在這種情況下，執行官在本協議下將沒有其他權利或義務（除第 4 和第 5(c)條款適用）。自生效日期起，本協議應取代雙方就本協議相關事項達成的任何其他協議，包括但不限於公司與執行官於2019年10月23日簽署的某份第二次修訂和再確認的僱傭協議，以及公司與執行官於2013年5月26日簽署的某份修訂和再確認的執行僱傭協議，以及公司與執行官於2012年2月13日簽署的某份執行僱傭協議（以及附帶的發明及保密協議和競爭協議）並取代與公司或其任何相關方之間的所有先前通信、協議和諒解，無論是書面還是口頭。


15

就高管的僱傭條款和條件而言，與其關聯公司或前任公司。

(h)行政部門同意，因本協議或雙方關係引起或與之相關的任何訴訟的管轄權和地點，包括但不限於與有效性、解釋、履行或執行有關的事項，應完全屬於位於坎伯蘭縣的緬因州聯邦和州法院（統稱”精選法院”）（前提是對任何此類訴訟的最終判決應是決定性的，並在其他司法管轄區強制執行），並進一步同意可以法律允許的任何方式送達訴訟程序。行政部門不可撤銷地放棄並同意不主張 (i) 對特定法院因本協議或本協議所設想的交易而產生的任何訴訟或訴訟的地點提出任何異議，以及 (ii) 聲稱在任何此類法院提起的任何此類訴訟是在不方便的法庭上提起的任何索賠。本第14（h）條旨在確定雙方之間潛在訴訟的地點，不構成任何訴訟理由，也不會放棄任何訴訟辯護或豁免權，也不會剝奪當事方就與本協議或本協議下高管僱用相關的任何衝突達成仲裁的權利。各方在合法範圍內放棄由陪審團審判的任何權利，並同意其中任何一方均可向任何法院提交本段的副本，作爲雙方明知、自願和討價還價協議的書面證據，不可撤銷地放棄其在雙方之間與本協議或預期交易有關的任何訴訟中接受陪審團審判的權利。

(i)在可能的情況下，本協議的每一條款或條款的任何部分，包括附件中的發明和保密協議，將被解讀爲在適用法律下有效且有效，但本協議的任何條款或條款的任何部分在任何司法管轄區的無效或不可強制性不應影響本協議在該司法管轄區的其餘部分的有效性或可強制性，或在任何其他司法管轄區的有效性或可強制性，包括該條款或條款的任何部分。附錄 A與本協議附帶的競業禁止協議附件B此外，如果法院或仲裁者判斷本協議的任何條款或條款的任何部分，包括附件中的發明和保密協議，附錄 A與本協議附帶的競業禁止協議附件B, 在時間段、地理區域或其他方面均不合理或無效，雙方同意該條款應在裁判或仲裁者認爲合理或有效的最大範圍內進行解釋和執行。

(j)本協議可以通過.pdf或傳真簽名執行，且可以有任意數量的副本，每一份副本都應視爲原件，但所有這些副本應共同構成一份相同的文書。

[頁面其餘部分故意留空]


16

此證明執行官在此簽署並根據董事會的授權，公司已以其名義執行本文件，均在上述日期和年份之上。

執行：

/s/ 喬納森·傑·馬澤爾斯基

喬納森（傑）·馬澤爾斯基

公司：

IDEXX實驗室公司

作者：/s/ 香農·E·安德伯格

姓名：Sharon E. Underberg

職位：執行副總裁、總法律顧問及公司秘書

[第三次修訂及重述的執行僱傭協議簽名頁]

附錄 A

發明和不披露協議

附加的

A-1

附件A

保密信息、工作成果和限制性契約協議

本機密信息、工作產品和限制性契約協議（「協議」）由IDEXX Laboratories, Inc.及其母公司、子公司、關聯公司、前任、繼任者和受讓人（“）與下方簽名的個人（“）共同簽署（統稱爲「雙方」，單獨稱爲「一方」）。公司）和下方簽名的個人（“員工）共同簽署（統稱爲「雙方」，單獨稱爲「一方」）。

鑑於公司和員工同意，公司在其機密信息（定義如下）和商業祕密（定義如下）以及投入大量時間、金錢、培訓、團隊建設和其他努力以發展員工的技能、協助員工履行其對公司的職責方面，具有合法的業務利益，包括建立、開發和維護與公司客戶及員工的良好關係，所有這些員工同意公司爲此投入了大量資源，這些都是公司的寶貴資產。

鑑於公司與員工同意，公司機密信息和交易祕密，包括關於客戶和員工的關鍵信息及其聲譽，並不爲公衆所知，是經過時間積累並付出了巨大的成本，並且公司採取了合理的保護措施以防止泄露給未經授權的第三方；

鑑於作爲履行員工在公司的職責的一部分，員工將有權訪問和/或使用公司的機密信息和交易祕密，並與客戶和員工合作；並且

鑑於, 公司與員工同意此協議是合理的，旨在保護公司免受員工離開公司（無論出於何種原因）後使用或披露其機密信息和交易祕密以及/或干擾公司與客戶和員工之間的良好關係所造成的不可挽回的傷害。

因此，爲了獲得良好和有價值的對價，員工在不簽訂本協議的情況下，本不應有權獲得的，包括：（a）本協議中包含的承諾和契約；（b）員工與公司的僱傭或繼續僱傭；

(c) 員工訪問和使用公司機密信息及商業祕密，包括關於其客戶和員工的關鍵信息以及商譽；(d) 公司爲員工提供的專業培訓，以使員工能夠履行其在公司的職責；和/或 (e) 其他良好且有價值的貨幣考慮，公司和員工同意如下（包括上述前言，明確併入本協議）：

1.披露. 爲了維護員工的保密義務，避免可能出現的利益衝突，員工將在接受任何新的職位之前，將本協議的存在及員工因其而產生的保密和限制性契約義務的性質披露（並允許公司向任何未來的潛在僱主披露）。

2.定義.

2.1.“機密信息”是指在公司業務中創造和使用的信息，這些信息一般不爲公衆所知，包括但不限於：商業祕密、專有或定製的軟件和數據庫（包括但不限於獸醫

與患者預約和護理、客戶信息和通信（包括遠程醫療）、藥物管理和處方以及業務和/或人員管理與發展等問題相關的實踐管理平台；公司的製造過程和方法、產品配方、用於或正在開發的研究與開發（包括但不限於與實驗室產品、儀器、設備及在獸醫和/或人類醫學中使用的消耗品的製造相關的內容）；新產品計劃；公司與現有或潛在客戶有關的機密記錄，包括關鍵客戶聯繫信息、合同條款及相關信息；機密商業機會；合併或收購活動（包括目標、機會或前景）；有關供應商或供應商的信息，包括關鍵供應商或供應商的聯繫信息、合同條款及相關信息；廣告和營銷策略；機密商業流程和策略，包括培訓、政策和程序；人員組成（工資、專業化等）；財務和營業收入數據及報告，包括定價、報價和賬單方法；以及公司保持機密的任何其他商業信息。員工具體理解並同意，機密信息一詞還包括在員工與公司就業過程中或由於此而可能被傳達、獲取、得知或開發的任何第三方機密信息。機密信息不包括來自公司外部的、可能被員工或公衆知曉的信息，且並非因違反本協議而知曉，或在得到公司書面批准後由員工披露的。

2.2.“競爭產品或服務“指任何其他個人或組織（存在或正在開發中的）與公司相同、相似或競爭的任何產品、過程、系統或服務，以及員工在過去二十四（24）個月內在公司工作或負責的產品、過程、系統或服務（存在或正在開發中）。

2.3.“競爭者「員工」指的是參與或即將參與競爭產品或服務的研究或開發、生產、營銷、租賃、銷售或服務的任何其他人員或組織。

2.4.“客戶”是指在最後一天之前的二十四（24）個月內，員工直接或間接地（例如，通過員工的監督）：（a）提供與公司業務相關的產品或服務；或（b）提供有關接收公司產品或服務的書面提案。

2.5.“生效日期「」指的是本協議的條款或其中任何條款可以被任何一方執行的日期。

1.1.1.1.關於下面第3.1節中規定的禁止競爭限制，生效日期是指發生在以下日期中的較晚者： (a) 員工與公司開始僱傭關係後的滿一年，或者 (b) 員工簽署本協議後的六（6）個月。對於(i) 在2019年9月19日前與公司簽署了包含任何禁止競爭限制的協議，並且 (ii) 自簽署該協議以來持續在公司工作的員工，將在本協議第3.1節的禁止競爭限制生效日期之前一直受到該限制的約束。隨後，本協議的條款將完全取代該等之前的協議。

1.1.1.2.關於本協議中除第3.1條以外的所有條款，生效日期是指員工簽署本協議的日期。

2.6.“間接意思是（包括在第2.4節中定義的）員工將不會協助他人進行員工在本協議中被禁止直接從事的業務活動。

2.7.“最後一天指員工與公司結束僱傭關係的最後一天，無論員工離職的原因是什麼，包括有因或無因，自願或非自願。這不包括員工在公司各實體之間的連續僱傭。如下所述，這種調動將被視爲在本協議和這些契約下不間斷和持續的僱傭關係。

2.8.“限制性地理區域”指的是在過去二十四（24）個月中，最後一天之前的領土（即: (i) 國家（們），(ii) 州（們），(iii) 縣（們），或 (iv) 城市（們）在這些地方： (a) 員工代表公司提供服務； (b) 員工向客戶進行招攬或以其他方式代表公司銷售產品或服務； (c) 公司銷售產品或服務，且員工擁有關於(i) 公司在該領土的業務和/或 (ii) 在該領土銷售的產品或服務的機密信息；和/或 (d) 在員工監督下提供服務、招攬客戶或以其他方式代表公司銷售產品或服務的個人。

2.9.“限制期“指員工與公司僱傭關係的期限以及最後一天後的二十四（24）個月。員工認識到，這個期限是合理且恰當地符合公司的合法業務利益以及對員工在公司所持職位的保護需要。

2.10.“商業祕密“是指根據適用州法律或2016年保護商業祕密法定義的信息。

3.限制性契約爲了保護公司的合法業務利益，包括員工對公司機密信息和商業祕密的訪問和使用，包括有關其推薦來源、客戶和員工的關鍵資料及良好聲譽，員工同意如下：

3.1.非競爭. 在生效日期之前，如果員工受限於2019年9月19日之前生效的協議，員工仍將受該等先前協議的約束。在生效日期之後，在限制期間及限制地域內，員工不得直接或間接地從事員工爲公司在競爭產品或服務方面所執行的相同或類似職責。儘管有上述規定，但員工可以接受多元化經營的競爭對手的工作，前提是： (a) 員工不得參與與競爭產品或服務相關的工作，或以其他方式使用或披露機密信息或商業祕密； (b) 公司應在員工和競爭對手之間獲得事先書面確保，並對此感到滿意，以確認員工將不從事或提供競爭產品或服務，或以其他方式使用或披露機密信息或商業祕密。此外，本協議中的任何內容均不旨在阻止員工將其資金投資於與公司直接競爭的某人的證券，如果該人的證券在註冊證券交易所上市交易或在場外市場積極交易，並且員工的持股量少於該人已發行股票或證券本金數額的百分之一（1%）。

3.2.禁止誘導和引誘客戶. 在限制期間，與競爭產品或服務相關，員工不得直接或間接： (a) 誘使或試圖誘使任何客戶；或 (b) 誘導或鼓勵任何客戶終止與公司的關係或以其他方式停止接受公司的服務或產品。

3.3.不拉客和不誘導員工。在限制期內，員工不得直接或間接：(a) 索取、招聘、鼓勵（或試圖招募、招募或鼓勵），或通過協助他人拉客、招聘或鼓勵任何與員工共事、有業務聯繫或員工獲得非公開或機密信息的公司僱員或前僱員（「員工或前員工」）；(b) 爲入職目的與員工或前僱員聯繫或溝通協助、鼓勵和/或協助他們終止其任期在公司工作或找工作或在其他個人或實體工作；(c) 向任何個人或實體提供或傳遞有關任何員工或前僱員的姓名、聯繫方式和/或背景信息，或提供推薦人或有關他們的任何其他信息；(d) 向員工或前僱員提供或傳遞有關潛在工作或實體或人員的任何信息，包括但不限於職位空缺、職位發佈或姓名或聯繫信息僱用人員的個人或公司或接受求職申請；和/或（e）向任何員工或前僱員提供工作或工作。就本契約而言，「前員工」是指在嘗試招聘或招聘時未受公司僱用，但在試圖招聘、僱用和/或干預之前的三 (3) 個月內受僱於公司或在公司工作的員工。

3.4.條款是合理的. 員工確認並同意：本節中的條款對於保護公司的機密信息、商業祕密以及客戶和員工的良好信譽是必要和重要的；該條款的區域、期限和範圍是合理且必要的，以保護公司；它們不會過度壓迫或限制員工在其所選擇的職業中謀生的能力；它們並不是對員工的交易或可能涉及的任何公共利益的過度限制；員工同意受此類條款約束是有良好且有價值的考慮；公司有合法的業務目的，要求員工遵守本節中列出的條款。

4.Confidential Information and Trade Secrets.

4.1.訪問和使用。員工明確承認並同意，通過員工在公司工作和履行員工對公司的職責，員工將有權訪問和使用某些機密信息和商業祕密，並且此類機密信息和商業祕密構成公司的機密和專有商業信息和/或商業祕密，所有這些都是公司的專有財產。因此，員工同意，未經公司事先書面同意，員工不會也不會允許任何其他個人或實體直接或間接地：(a) 爲公司以外的任何個人或實體的利益使用機密信息或商業祕密；(b) 刪除、複製、複製或以其他方式複製任何體現或與任何機密信息或商業祕密有關的文件或有形物品，履行公司責任的要求除外；以及 (c) 在受僱期間及以後, 發佈, 發佈,通過任何通信，包括口頭、文件、電子或磁性信息傳輸設備或媒體，披露、交付或以其他方式向任何第三方提供任何機密信息或商業祕密。

4.2.保密信息和交易祕密的持續時間此保密和不使用的義務在信息仍然保密的情況下持續。員工理解，如果員工主要在任何要求對保密條款設定時間限制的州居住和工作，保密信息應受到保護，期限不少於兩（2）年。

最後一天。員工也理解商業機密受法律保護，並且不受任何時間限制。如果員工對這些信息是否爲受保護信息有任何疑問，還同意在使用、披露或分發任何機密信息或商業機密之前聯繫公司。

4.3.2016年《保護商業祕密法》下的豁免權. 員工在任何聯邦或州的商業祕密法下，不因泄露以下商業祕密而被追究刑事或民事責任： (a) 在以下情況下披露的： (i) 以保密方式直接或間接向聯邦、州或地方政府官員或律師披露，僅爲報告或調查涉嫌違法行爲的目的；或 (b) 在訴訟或其他程序中以投訴或其他文件形式披露的，但該文件是密封提交的。根據該法，在某些情況下，向律師披露的信息、密封提交的信息或根據法院命令披露的信息也是受到保護的。

4.4.對保密義務的額外法律例外本協議中的任何內容不得解釋爲阻止按適用法律或法規要求披露機密信息；特別是對於聯邦或州行政機構（例如，、平等就業機會委員會、相應的州就業機構等），或根據具有管轄權的法院的有效命令或授權政府機構的命令，前提是披露的內容不超過該法律、法規或命令要求的披露範圍。對於具有管轄權的法院的命令，員工將及時向公司的總法律顧問提供任何此類命令的書面通知。如果公司選擇尋求保護性命令或其他救濟，員工將全力配合公司。如果公司未獲得保護性命令或其他救濟或放棄遵守本協議的某些條款，員工將僅提供在律師書面意見中認定爲法律要求披露的機密信息部分，並將盡最大努力獲得對該披露的機密信息予以保密處理的保證。此外，本協議中的任何內容不會以任何方式禁止或旨在限制或妨礙，並且不應被解釋或理解爲限制或妨礙員工根據《國家勞動關係法》第7條行使員工的權利或根據法律允許的其他方式披露信息。

5.公司財產和信息的歸還員工同意在最後一天（或公司要求時提前）立即將所有屬於公司的財產和信息（以電子或紙質形式）歸還給公司。員工還應向公司披露員工計算機的任何密碼或與員工在公司工作相關的其他訪問代碼，並在歸還公司財產之前不得刪除、修改或更改任何財產。員工還應向公司提供訪問任何個人計算機、平板電腦、手機、外部硬盤、U盤、基於雲的存儲平台或任何其他存有公司信息的個人設備或存儲位置的權限，無論該信息是否被指定爲機密或專有信息，以便公司可以刪除或移除任何公司信息。

6.發明和原創作品的轉讓.

6.1.先前的發明和創造作品員工理解員工的義務（在員工簽署本協議之日或之前）書面通知公司員工的任何先前發明或創造作品。員工未能做到這一點意味着不存在任何此類先前發明或創造作品。員工同意，不得將任何員工擁有或員工有利害關係的先前發明或創造作品，納入公司的產品、工藝、程序或機器，包括爲公司創建或開發的任何軟件代碼，或根據本協議條款公司擁有的利益，而未經公司的事先書面同意。先前的發明指的是所有

員工在入職公司之前所創造的發明，屬於員工並與公司的當前或擬議的業務、產品、服務或研發相關，並且未在本協議下由員工目前轉讓。創作作品指任何和所有的著作作品，包括例如：書面文件、電子表格、圖形、設計、商標、服務標誌、算法、計算機程序和代碼、協議、公式、掩膜版-半導體、宣傳冊、演示文稿、照片、音樂或作品、手冊、報告和各種元素的彙編。

6.2.發明的轉讓員工同意及時向公司全權書面披露，併爲公司的唯一權益持有信託，並即時將所有員工在員工的僱傭期間或最後一天後的一（1）年內發明的任何及所有發明的所有權利、所有權和利益轉讓給公司（或其指定者），而無需任何額外對價。員工理解本節下的義務不適用於未使用公司設備、供應、設施或機密信息或商業祕密而完全在員工自己時間內開發的任何發明，除非（a）該發明涉及（i）公司的業務，或者（ii）公司實際或明顯預期的研究或開發，或者（b）該發明是員工爲公司所做工作的直接結果。發明（們）指的是員工在正常工作時間內或在預期工作的時間內單獨或共同發明的發明、開發、概念、改進、設計、發現、設備、裝置、過程、做法、組合物、配方、機器、製造物品、方法（包括商業方法）、創造性想法、算法、計算機軟件代碼和程序、協議、配方、掩膜版-半導體、組合物、商標、服務標誌或商業祕密，無論是否實現、可專利或根據專利、版權、商標或類似法律可註冊，或者與公司的業務或公司實際或明顯預期的研究或開發相關，或在很大程度上得益於員工使用公司設備、供應、設施或機密信息或商業祕密，或包含公司任何機密信息或商業祕密，或是員工爲公司所做工作的直接或重大結果。發明,” “發明了，”和“發明過「意味着想象、開發、付諸實踐或以其他方式發明（如該術語通常被理解的），並不限於美國或外國專利法下的通用用法。」

6.3.僱傭作品. 僱員承認，所有在僱員與公司僱傭期間內（無論是單獨還是與他人共同）所創作的創作作品，凡是受版權保護的，均爲美國版權法（17 U.S.C. § 101）中定義的"僱傭作品"，並被視爲根據美國版權法特別委託給公司的作品。如果任何創作作品被認定爲不是"僱傭作品"，則本協議應視爲僱員對公司不可撤銷地轉讓該創作作品的所有適用的州、聯邦和國際版權、商標、服務標誌或其他類似權利，包括所有的權利、標題和利益。

6.4.專利和版權註冊員工同意（在職期間及離職後）協助公司（或其指定人員），在公司的費用下，但不向員工提供額外補償，以確保公司的權利，以及公司指示的任何政府實體或第三方對任何發明、版權或其他知識產權在任何國家的權利。如果公司因任何原因，包括公司在合理努力後無法找到員工或員工因心理或身體 incapacity，而無法獲得員工的簽名以申請或追求任何美國或外國專利或版權註冊或其他知識產權（或在任何轉讓其所有權的文件上）涵蓋根據本協議分配給公司的發明、以前的發明或創作作品，員工在此不可撤銷地指定並任命公司及其正式授權的官員和代理作爲員工的代理人和事實上的律師，代表員工行使權利並代替員工行事。

執行並提交任何此類申請和文件，並採取所有其他法律允許的行爲，以進一步推進專利或版權註冊或其轉讓的起訴，並具有與員工執行時相同的法律效力和效果。該任命與發明和創作作品的權益相結合，並應在員工去世或殘疾後繼續有效。

6.5.披露信息和保存記錄的義務員工同意在受僱期間及最後工作日後的兩（2）年內，立即以書面形式向公司披露所有由員工單獨或與他人共同創作或構思的發明和創意作品，以及所有試圖註冊、申請專利或以其他方式主張所有權或轉讓這些發明和創意作品的嘗試。

6.6.道德權利在法律允許的最大範圍內，本第6條款的權利轉讓包括所有的父權、完整性、披露和撤回權利以及任何其他可能被稱爲或稱爲「道德權利」、「藝術家權利」、「droit moral」或類似的權利（統稱，“道德權利）在員工根據適用法律保留任何此類道德權利的情況下，員工在此確認並同意（並提供所有必要的確認和同意）公司可能採取（或授權的）任何與此類道德權利相關的行動，員工同意不對此提出任何道德權利的主張。員工將根據公司的要求不時確認任何此類確認、同意和協議。

7.隨意僱傭. 員工承認並同意本協議中的任何內容都不是對任何特定期限內的就業保證或承諾。員工了解，員工是隨意僱傭員工，員工或公司可以在任何時間出於法律不禁止的任何原因終止這一隨意僱傭關係。

8.可分割性和改革。員工和公司同意，如果適當法院裁定本協議的任何特定段落、分段、短語、詞語或其他部分按書面形式無效或不可執行，則應根據需要對其進行修改，以符合雙方的合理意圖和期望，有利於爲公司的所有合法商業利益提供合理的保護，此類修改不得影響本協議的其餘條款，或者任何條款不能修改爲生效或可強制執行，則應將其與本協議分開，所有其餘條款和規定仍可執行。

9.收費公司保留要求的權利，員工將不予反對，主管轄區的法院可以將限制期限延長至員工違反本協議的任何時間段，以作爲公平救濟的形式，以便公司能充分獲得員工在限制性契約中所做承諾的全部利益。

10.救濟、補救和執法。員工承認並同意，員工違反本協議的任何條款將對公司造成嚴重且無法彌補的損害，這種傷害難以量化，光靠金錢賠償不足以補償公司。如果員工違反或威脅或故意違反本協議，公司有權獲得臨時和最終的禁令救濟，禁止和限制此類違規行爲或威脅或故意的違約行爲。員工進一步同意，如果員工違反本協議，公司將有權獲得任何其他法律或衡平法救濟，包括追回和退還爲簽訂本協議而支付給員工的任何款項，提取員工、任何後續僱主、員工擁有或經營的任何企業或任何員工的代理人、繼承人或受讓人實現的任何利潤、佣金或費用。員工還應向公司支付因員工違反本協議任何條款而產生的所有合理費用和律師費。

11.完整協議，修訂條款. 員工同意本協議構成雙方之間的完整協議和理解，除非在條款中具體描述。

1.1.1.根據上述3.1條款，或根據員工與公司總法律顧問簽署的書面協議，本協議取代了員工與公司之間就本協議範圍內所有事項的任何先前協議，無論是口頭還是書面。除非該放棄、修改或解除以書面形式達成一致並由員工和公司總法律顧問簽字，否則本協議的任何條款不得被修改、放棄或解除。本協議應根據其條款執行，不得對任何一方作出不利解釋。

12.No Conflicts. Employee represents and warrants that Employee’s performance of all the terms of this Agreement, and the performance of Employee’s duties as an employee of the Company or the fact of Employee’s employment with the Company, do not and will not breach any agreement between Employee and any other person, including any prior employer.

13.Survival. The obligations Employee has undertaken in this Agreement shall survive the Last Day and no dispute regarding any other provisions of this Agreement or regarding Employee’s employment or the termination of Employee’s employment shall prevent the operation and enforcement of these obligations.

14.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall constitute an original, and all of which shall constitute one instrument. A signature made on a

.PDF or facsimile copy of this Agreement or a signature to this Agreement transmitted by .PDF or facsimile shall have the same effect as an original signature.

15.Successors and Assigns. This Agreement shall be binding upon, and inure to the benefit of, the parties and their respective successors and permitted assigns. Employee may not assign Employee’s rights and obligations under this Agreement without prior written consent of the Company. The Company may assign this Agreement and/or its rights or obligations under this Agreement. Any and all rights and remedies of the Company under this Agreement shall inure to the benefit of and be enforceable by any successor or assignee of the Company.

16.Governing Law/Venue/Waiver. This Agreement shall be construed and enforced in accordance with the laws of the State of Maine without reference to principles of conflicts of laws. The parties stipulate that the exclusive venue for any legal proceeding arising out of this Agreement is the state and federal courts sitting in Portland, Maine (Cumberland County), and waives any defense, whether asserted by motion or pleading, that the venue specified by this section is an improper or inconvenient venue; provided that the Company may commence a legal proceeding in any other relevant jurisdiction for the purpose of enforcing its rights under this Agreement. The parties further agree that any disputes between them, whether relating to this Agreement or any other conflict, claim or dispute, shall be tried by a judge. The parties waive their rights to a jury trial of any dispute between them.

17.Electronic Signature. Employee agrees that the Company may enforce this Agreement with a copy for which Employee has provided an electronic signature, and that such electronic signature may be satisfied by procedures that the Company or a third party designated by the Company has established or may establish for an electronic signature system, and Employee’s electronic signature shall be the same as, and shall have the same force and effect as, Employee’s written signature. By electronically accepting this Agreement, Employee agrees to the following: “This electronic contract contains my electronic signature, which I have executed with the intent to sign this Agreement.”

IN WITNESS WHEREOF, the undersigned Employee has executed this Agreement freely and voluntarily with the intention of being legally bound by it.

________________________________

Signature

_____________________________

Print Name

_____________________

Date

Exhibit B

Non-Compete Agreement

Attached

B-1

EXHIBIT B

CONFIDENTIAL INFORMATION, WORK PRODUCT, AND RESTRICTIVE COVENANT AGREEMENT

This Confidential Information, Work Product, and Restrictive Covenant Agreement (“Agreement”) is made by and between IDEXX Laboratories, Inc. and its parents, subsidiaries, affiliates, predecessors, successors and assigns (the “Company”) and the undersigned individual (“Employee”) (collectively, the “Parties” and individually a “Party”).

WHEREAS, the Company and Employee agree that the Company has a legitimate business interest in, among other things, its Confidential Information (defined below) and Trade Secrets (defined below), and in the significant time, money, training, team building and other efforts it expends to develop Employee’s skills to assist Employee in performing Employee’s duties for the Company, including with respect to establishing, developing and maintaining the goodwill and business relationships with the Company’s customers and employees, all of which Employee agrees are valuable assets of the Company to which it has devoted substantial resources;

WHEREAS, the Company and Employee agree that the Company’s Confidential Information and Trade Secrets, including key information about, and goodwill in, its customers and employees are not generally known to the public, were developed over time and at significant cost to the Company, and are the subject of reasonable efforts of protection by the Company against disclosure to unauthorized parties; and

WHEREAS, as part of performing Employee’s duties for the Company, Employee will have access to and/or will use the Company’s Confidential Information and Trade Secrets and will work with customers and employees; and

WHEREAS, the Company and Employee agree that this Agreement is reasonable to protect the Company against the irreparable harm it would suffer if Employee left the Company’s employment (for any reason) and used or disclosed its Confidential Information and Trade Secrets, and/or interfered with the goodwill and relationships the Company has in its customers and employees.

NOW, THEREFORE, for good and valuable consideration, to which Employee would not otherwise be entitled without entering into this Agreement, including: (a) the promises and covenants contained in this Agreement; (b) Employee’s employment or continued employment with the Company;

(c) Employee’s access to and use of the Company’s Confidential Information and Trade Secrets, including key information about, and goodwill in, its customers and employees; (d) the specialized training the Company provides to Employee to allow Employee to perform Employee’s duties for the Company; and/or (e) other good and valuable monetary consideration, the Company and Employee agree as follows (including the foregoing recitals which are expressly incorporated in this Agreement):

1.Disclosures. In order to maintain Employee’s confidentiality obligations and to avoid conflicts of interest which may arise, Employee will disclose (and allow the Company to disclose) to any future prospective employers the existence of this Agreement and the nature of Employee’s confidentiality and restrictive covenant obligations arising from it before Employee accepts any new position of employment.

2.Definitions.

2.1.“Confidential Information” means information that is created and used in the Company’s business and which is not generally known by the public, including but not limited to: trade secrets, proprietary or customized software and databases (including, but not limited to, veterinary

practice management platforms relating to issues such as patient scheduling and care, customer information and communications (including telemedicine), medication management and prescriptions, and business and/or personnel management and development); manufacturing processes and methods, product formulas, research and development used by or in development for use or sale by the Company (including, but not limited to those relating to the manufacture of laboratory products, instruments, equipment, and consumables used in veterinary and/or human medicine); new product plans; the Company’s confidential records pertaining to its existing or potential customers, including key customer contact information, contract terms and related information; confidential business opportunities; merger or acquisition activity (including targets, opportunities, or prospects); confidential information regarding suppliers or vendors, including key supplier or vendor contact information, contract terms and related information; strategies for advertising and marketing; confidential business processes and strategies, including training, policies and procedures; personnel composition (wages, specialization, etc.); financial and revenue data and reports, including pricing, quoting and billing methods; and any other business information that the Company maintains as confidential. Employee specifically understands and agrees that the term Confidential Information also includes all confidential information of a third party that may be communicated to, acquired by, learned of, or developed by Employee in the course of or as a result of Employee’s employment with the Company. Confidential Information does not include information that is or may become known to Employee or to the public from sources outside the Company and through means other than a breach of this Agreement or disclosed by Employee after written approval from the Company.

2.2.“Competitive Product or Service” means any product, process, system or service (in existence or under development) of any person or organization other than the Company that is the same as, similar to, or competes with, a product, process, system or service (in existence or under development) upon which Employee worked or had responsibilities at the Company during the twenty- four (24) months prior to the Last Day (as defined below).

2.3.“Competitor” means Employee or any other person or organization engaged in or about to become engaged in, research or development, production, marketing, leasing, selling, or servicing of a Competitive Product or Service.

2.4.“Customer” means any person(s) or entity(ies) whom, within twenty-four (24) months prior to the Last Day, Employee, directly or Indirectly (e.g., through employees whom Employee supervised): (a) provided products or services in connection with the Company’s business; or (b) provided written proposals concerning receiving products or services from the Company.

2.5.“Effective Date” means the date on which the provisions of this Agreement, or any of them, may be enforced by any Party.

1.1.1.1.With respect to the Non-Competition restrictions set forth in Section 3.1 below, the Effective Date refers to the later of the date that occurs (a) one year after Employee’s commencement of employment with the Company or (b) six (6) months after Employee’s execution of this Agreement. Employees who (i) prior to September 19, 2019, executed an agreement with the Company that contains any non-competition restriction and (ii) have remained continuously employed by the Company since executing such an agreement shall remain bound by such restrictions until the Effective Date of the Non-Competition restrictions in Section 3.1 of this Agreement. Thereafter, the terms of this Agreement shall fully supersede such prior agreement(s).

1.1.1.2.With respect to all provisions of this Agreement other than Section 3.1, Effective Date refers to the date on which Employee executes this Agreement.

2.6.“Indirectly” means (including as defined in Section 2.4) that Employee will not assist others in performing business activities that Employee is prohibited from engaging in directly under this Agreement.

2.7.“Last Day” means Employee’s last day of employment with the Company regardless of the reason for Employee’s separation, including with or without cause, voluntary or involuntary. It does not encompass Employee’s continuous employment between Company entities. As referenced below, such movement shall be deemed as unbroken and continued employment under this Agreement and these covenants.

2.8.“Restricted Geographic Area” means the territory (i.e.: (i) country(ies) (ii) state(s), (iii) county(ies), or (iv) city(ies)) in which, during the twenty-four (24) months prior to the Last Day: (a) Employee provided services on behalf of the Company; (b) Employee solicited Customers or otherwise sold products or services on behalf of the Company; (c) the Company sold products or services and Employee had Confidential Information about (i) the Company’s business in the territory and/or (ii) the products or services sold in the territory; and/or (d) individuals supervised by Employee provided services, solicited Customers, or otherwise sold products or services on behalf of the Company.

2.9.“Restricted Period” means the period of Employee’s employment with the Company and a period of twenty-four (24) months after the Last Day. Employee recognizes that this durational term is reasonably and narrowly tailored to the Company’s legitimate business interest and need for protection with each position Employee holds at the Company.

2.10.“Trade Secret” means information defined as a trade secret under applicable state law or the Defend Trade Secrets Act of 2016.

3.Restrictive Covenants. To protect the Company’s legitimate business interests, including with respect to Employee’s access to and use of the Company’s Confidential Information and Trade Secrets, including key information about, and goodwill in, its referral sources, customers and employees, Employee agrees that:

3.1.Non-Competition. Prior to the Effective Date, if the Employee is subject to an agreement effective before September 19, 2019, the Employee shall remain bound by any such prior agreement(s). Following the Effective Date, during the Restricted Period and within the Restricted Geographic Area, Employee will not, directly or Indirectly, perform the same or similar responsibilities Employee performed for the Company in connection with a Competitive Product or Service. Notwithstanding the foregoing, Employee may accept employment with a Competitor whose business is diversified, provided that: (a) Employee will not be engaged in working on or providing Competitive Products or Services or otherwise use or disclose Confidential Information or Trade Secrets; and (b) the Company receives prior written assurances from the Competitor and Employee that are satisfactory to the Company that Employee will not work on or provide Competitive Products or Services, or otherwise use or disclose Confidential Information or Trade Secrets. In addition, nothing in this Agreement is intended to prevent Employee from investing Employee’s funds in securities of a person engaged in a business that is directly competitive with the Company if the securities of such a person are listed for trading on a registered securities exchange or actively traded in an over-the-counter market and Employee’s holdings represent less than one percent (1%) of the total number of outstanding shares or principal amount of the securities of such a person.

3.2.Non-Solicitation and Non-Inducement of Customers. During the Restricted Period and in connection with a Competitive Product or Service, Employee shall not directly or Indirectly: (a) solicit or attempt to solicit any Customer; or (b) induce or encourage any Customer to terminate a relationship with the Company or otherwise to cease accepting services or products from the Company.

3.3.Non-Solicitation and Non-Inducement of Employees. During the Restricted Period, Employee shall not directly or Indirectly: (a) solicit, recruit, encourage (or attempt to solicit, recruit or encourage), or by assisting others in soliciting, recruiting or encouraging, any Company employees or former employees with whom Employee worked, had business contact, or about whom Employee gained non-public or Confidential Information (“Employees or Former Employees”); (b) contact or communicate with Employees or Former Employees for the purpose of inducing, assisting, encouraging and/or facilitating them to terminate their employment with the Company or find employment or work with another person or entity; (c) provide or pass along to any person or entity the name, contact and/or background information about any Employees or Former Employees or provide references or any other information about them; (d) provide or pass along to Employees or Former Employees any information regarding potential jobs or entities or persons for which to work, including but not limited to job openings, job postings, or the names or contact information of individuals or companies hiring people or accepting job applications; and/or (e) offer employment or work to any Employees or Former Employees. For purposes of this covenant, “Former Employees” shall refer to employees who are not employed by the Company at the time of the attempted recruiting or hiring, but were employed by, or working for the Company in the three (3) months prior to the time of the attempted recruiting or hiring and/or interference.

3.4.Covenants are Reasonable. Employee acknowledges and agrees that: the covenants in this section are necessary and essential to protect the Company’s Confidential Information, Trade Secrets and the goodwill in its customers and employees; the area, duration and scope of the covenants in this section are reasonable and necessary to protect the Company; they do not unduly oppress or restrict Employee’s ability to earn a livelihood in Employee’s chosen profession; they are not an undue restraint on Employee’s trade or any of the public interests that may be involved; good and valuable consideration exists for Employee’s agreement to be bound by such covenants; and the Company has a legitimate business purpose in requiring Employee to abide by the covenants set forth in this section.

4.Confidential Information and Trade Secrets.

4.1.Access and Use. Employee expressly acknowledges and agrees that, by virtue of Employee’s employment with the Company and exercise of Employee’s duties for the Company, Employee will have access to and will use certain Confidential Information and Trade Secrets, and that such Confidential Information and Trade Secrets constitute confidential and proprietary business information and/or Trade Secrets of the Company, all of which is the Company’s exclusive property. Accordingly, Employee agrees that Employee will not, and will not permit any other person or entity to, directly or Indirectly, without the prior written consent of the Company: (a) use Confidential Information or Trade Secrets for the benefit of any person or entity other than the Company; (b) remove, copy, duplicate or otherwise reproduce any document or tangible item embodying or pertaining to any of the Confidential Information or Trade Secrets, except as required to perform responsibilities for Company; and (c) while employed and thereafter, publish, release, disclose, deliver or otherwise make available to any third party any Confidential Information or Trade Secrets by any communication, including oral, documentary, electronic or magnetic information transmittal device or media.

4.2.Duration of Confidential Information and Trade Secrets. This obligation of non- disclosure and non-use shall last so long as the information remains confidential. Employee, however, understands that, if Employee primarily lives and works in any state requiring a temporal limit on non- disclosure clauses, Confidential Information shall be protected for no less than two (2) years following the

Last Day. Employee also understands that Trade Secrets are protected by statute and are not subject to any time limits. Employee also agrees to contact the Company before using, disclosing, or distributing any Confidential Information or Trade Secrets if Employee has any questions about whether such information is protected information.

4.3.Immunity under the Defend Trade Secrets Act of 2016. Employee shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a Trade Secret that: (a) is made (i) in confidence to a Federal, State, or local government official, either directly or Indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Disclosures to attorneys, made under seal, or pursuant to court order are also protected in certain circumstances under said Act.

4.4.Additional Legal Exceptions to Non-Disclosure Obligations. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation; especially with respect to a federal or state administrative agency (e.g., EEOC, equivalent state employment agency, etc.), or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order. With respect to an order of a court of competent jurisdiction, Employee will promptly provide the General Counsel of the Company with written notice of any such order. If the Company chooses to seek a protective order or other remedy, Employee will cooperate fully with the Company. If the Company does not obtain a protective order or other remedy or waives compliance with certain provisions of this Agreement, Employee will furnish only that portion of the Confidential Information which, in the written opinion of counsel, is legally required to be disclosed and will use its best efforts to obtain assurances that confidential treatment will be accorded to such disclosed Confidential Information. In addition, nothing in this Agreement in any way prohibits or is intended to restrict or impede, and shall not be interpreted or understood as restricting or impeding, Employee from exercising Employee’s rights under Section 7 of the National Labor Relations Act (NLRA) or otherwise disclosing information as permitted by law.

5.Return of Company Property and Information. Employee agrees that upon the Last Day (or earlier if requested by the Company) to immediately return to the Company all property and information belonging to the Company (in electronic or hard-copy form). Employee shall also disclose to the Company any passwords for Employee’s computer or other access codes for anything associated with Employee’s employment with the Company, and shall not delete or modify or alter any property prior to its return to the Company. Employee also shall provide the Company with access to any personal computer, tablet, phone, external hard drives, flash drives, cloud-based storage platforms, or any other personal device or storage location with Company information, whether or not such information is designated as confidential or proprietary, so that the Company may remove or delete any Company information.

6.Assignment of Inventions and Original Works.

6.1.Prior Inventions and Creative Works. Employee understands Employee’s obligation (on or before the date Employee executes this Agreement) to identify to the Company in writing any of Employee’s Prior Inventions or Creative Works. Employee’s failure to do so means that no such Prior Inventions or Creative Works exist. Employee agrees not to incorporate, or permit to be incorporated, any Prior Invention or Creative Works owned by Employee, or in which Employee has an interest, into a Company product, process, program, or machine, including any software code created or developed on the Company’s behalf or in which the Company has an ownership interest pursuant to the terms of this Agreement, without the Company’s prior written consent. “Prior Inventions” means all

Inventions that were made by Employee prior to Employee’s employment with the Company, that belong to Employee and which relate to the Company’s current or proposed business, products, services, or research and development, and are not presently assigned by Employee under this Agreement. “Creative Works” means any and all works of authorship including, for example, written documents, spreadsheets, graphics, designs, trademarks, service marks, algorithms, computer programs and code, protocols, formulas, mask works, brochures, presentations, photographs, music or compositions, manuals, reports, and compilations of various elements.

6.2.Assignment of Inventions. Employee agrees to promptly make full written disclosure to the Company of, to hold in trust for the sole right and benefit of the Company, and presently assign to the Company (or its designees), without any additional consideration, all of Employee’s right, title, and interest in and to any and all Inventions that Employee Invents during Employee’s employment or for a period of one (1) year following the Last Day. Employee understands that the obligations under this section do not apply to any Invention for which no equipment, supplies, facility, or Confidential Information or Trade Secrets of the Company was used and which was developed entirely on Employee’s own time, unless (a) the Invention relates (i) to the business of the Company, or (ii) to the Company’s actual or demonstrably anticipated research or development, or (b) the Invention results from any work performed by Employee for the Company. “Invention(s)” means inventions, developments, concepts, improvements, designs, discoveries, devices, apparatus, processes, practices, compositions, formulas, machines, articles of manufacture, methods (including business methods), inventive ideas, algorithms, computer software code and programs, protocols, formulas, mask works, compositions, trademarks, service marks, or trade secrets, whether or not reduced to practice, patentable, or registrable under patent, copyright, trademark, or similar laws, which Employee Invents, either solely or jointly, during normal working hours or when Employee is expected to be working, or that relate to the business of the Company or to the Company’s actual or demonstrably anticipated research or development, or that are substantially aided by Employee’s use of the Company’s equipment, supplies, facilities, or Confidential Information or Trade Secrets, or contains any of the Company’s Confidential Information or Trade Secrets, or that are the direct or substantial result of any work performed by Employee for the Company. “Invent,” “Invents,” and “Invented” means to conceive of, develop, reduce to practice, or otherwise invent (as that term is commonly understood) and is not limited to its general usage under U.S. or foreign patent law.

6.3.Works Made for Hire. Employee acknowledges that all Creative Works that are made by Employee (solely or jointly with others) within the scope of and during the period of Employee’s employment with the Company and which are protectable by copyright are “works made for hire,” as that term is defined in the United States Copyright Act (17 U.S.C. § 101) and are deemed specially ordered by the Company under the U.S. Copyright law. In the event that any Creative Work is determined not to be a “work made for hire,” this Agreement shall operate as an irrevocable assignment by Employee to the Company of all applicable state, federal, and international copyrights, trademarks, service marks, or other similar rights in the Creative Work, including all right, title, and interest.

6.4.Patent and Copyright Registrations. Employee agrees (both during and after employment) to: assist the Company (or its designees), at the Company’s expense, but without additional compensation to Employee, to secure the Company’s rights, as well as the rights of any government entities or third parties to which the Company directs any assignment, in any Inventions, copyrights, or other intellectual property rights in any and all countries. If the Company is unable for any reason whatsoever, including the Company’s inability after expending reasonable efforts to locate Employee or the Employee’s mental or physical incapacity, to secure Employee’s signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations or other intellectual property rights (or on any document transferring ownership thereof) covering Inventions, Prior Inventions, or Creative Works assigned to the Company under this Agreement, Employee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Employee’s agent and attorney-in-fact to act for and on Employee’s behalf and in Employee’s stead to

execute and file any such applications and documents and to do all other lawfully permitted acts to further the prosecution and issuance of patents or copyright registrations or transfers thereof with the same legal force and effect as if executed by Employee. This appointment is coupled with an interest in and to the Inventions and Creative Works and shall survive Employee’s death or disability.

6.5.Duty to Disclose Information and Maintain Records. Employee agrees that while employed and for two (2) years following the Last Day, to promptly disclose to the Company in writing all Inventions and Creative Works authored or conceived by Employee, alone or jointly with others, along with all attempts to register, patent, or otherwise claim ownership over or alienate such Inventions and Creative Works.

6.6.Moral Rights. To the maximum extent allowed by law, the assignment of rights in this Section 6 includes all rights of paternity, integrity, disclosure, and withdrawal and any other rights that may be known as or referred to as “moral rights,” “artist’s rights,” “droit moral” or the like (collectively, “Moral Rights”). To the extent that Employee retains any such Moral Rights under applicable law, Employee hereby ratifies and consents to ( and provides all necessary ratifications and consents to) any action that may be taken with respect to such Moral Rights by ( or authorized by) the Company, and Employee agrees not to assert any Moral Rights with respect thereto. Employee will confirm any such ratifications, consents and agreements from time to time as requested by the Company.

7.At-Will. Employee acknowledges and agrees that nothing in this Agreement is a guarantee or assurance of employment for any specific period of time. Employee understands that Employee is an at-will employee and that either Employee or Company may terminate this at-will employment relationship at any time for any reason not prohibited by law.

8.Severability and Reformation. Employee and the Company agree if any particular paragraphs, subparagraphs, phrases, words, or other portions of this Agreement are determined by an appropriate court to be invalid or unenforceable as written, they shall be modified as necessary to comport with the reasonable intent and expectations of the parties and in favor of providing reasonable protection to all of the Company’s legitimate business interests, and such modification shall not affect the remaining provisions of this Agreement, or if any provision(s) cannot be modified to be made valid or enforceable, then they shall be severed from this Agreement, and all remaining terms and provisions shall remain enforceable.

9.Tolling. The Company reserves the right to request, and Employee will not object, that a court of competent jurisdiction extend the Restricted Period for any period of time that Employee is in breach of this Agreement as a form of equitable relief so that the Company receives the full benefit of Employee’s promises in the restrictive covenants.

10.Relief, Remedies and Enforcement. Employee acknowledges and agrees that a breach of any provision of this Agreement by Employee will cause serious and irreparable injury to the Company that will be difficult to quantify and that money damages alone will not adequately compensate the Company. In the event of a breach or threatened or intended breach of this Agreement by Employee, the Company shall be entitled to injunctive relief, both temporary and final, enjoining and restraining such breach or threatened or intended breach. Employee further agrees that should Employee breach this Agreement, the Company will be entitled to any and all other legal or equitable remedies available to it, including the recovery and return of any amount paid to Employee to enter into this Agreement, the disgorgement of any profits, commissions, or fees realized by Employee, any subsequent employers, any business owned or operated by Employee, or any of Employee’s agents, heirs, or assigns. Employee shall also pay the Company all reasonable costs and attorneys’ fees the Company incurred because of Employee’s breach of any provisions of this Agreement.

11.Entire Agreement, Amendments. Employee agrees that this Agreement constitutes the entire agreement and understanding between the parties and, except as specifically described in Sections

2.5.1 and 3.1 above, or otherwise agreed to in a writing signed by Employee and the General Counsel of the Company, this Agreement supersedes any prior agreements, either oral or in writing, between Employee and the Company with respect to all matters within the scope of this Agreement. No provision of this Agreement may be modified, waived, or discharged unless such waiver, modification, or discharge is agreed to in writing and signed by Employee and the General Counsel of the Company. This Agreement shall be enforced in accordance with its terms and shall not be construed against either party.

14.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall constitute an original, and all of which shall constitute one instrument. A signature made on a

.PDF or facsimile copy of this Agreement or a signature to this Agreement transmitted by .PDF or facsimile shall have the same effect as an original signature.

IN WITNESS WHEREOF, the undersigned Employee has executed this Agreement freely and voluntarily with the intention of being legally bound by it.

_____________________________

Signature

________________________________

Print Name

___________________

Date

Exhibit C

YOU SHOULD CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS RELEASE OF CLAIMS.

RELEASE

Capitalized terms used in this release and defined in the Employment Agreement (defined below) shall have the meanings given to such terms under the Employment Agreement.

1.In consideration of the payments and benefits to be made under the Third Amended and Restated Executive Employment Agreement, dated as of August 2, 2024 (the “Employment Agreement”), by and between Jonathan (Jay) Mazelsky (the “Employee” or “you”) and IDEXX Laboratories, Inc. (the “Company”), its subsidiaries and affiliates (hereinafter collectively referred to as “IDEXX”), the sufficiency of which you acknowledge, by signing this general release of claims (the “Release”), you and your heirs and assigns hereby fully, forever, irrevocably and unconditionally release and discharge IDEXX Laboratories, Inc., its subsidiaries and affiliates, and all of their respective former and current officers, directors, owners, stockholders, affiliates, agents, employees, and attorneys (collectively the “Released Parties”) from, and waive, any and all claims, charges, or actions of any kind which you have ever had or now have through the Release Effective Date (as defined below), whether known or unknown, against any or all of the Released Parties, arising out of or relating to your employment or termination from employment, including but not limited to claims under the Employment Agreement, claims under any severance plan maintained by IDEXX, claims for discrimination based on race, sex, disability, national origin, age, religion, color, ancestry, marital or family status, pregnancy, sexual orientation, and any other legally protected attribute or status, and including without limitation claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Rehabilitation Act of 1973, the Employee Retirement Income Security Act, the Equal Pay Act, the Americans with Disabilities Act, the Family and Medical Leave Act, the National Labor Relations Act, the Maine Human Rights Act, and all other applicable state laws, including but not limited to, laws pertaining to wrongful discharge claims, defamation claims, retaliation claims, unpaid wage claims, or other statutory or common law or contract claims. You acknowledge that this release releases the Released Parties in both their corporate and their individual capacities.

Without limiting the above, this Release also constitutes a release of any claims you may have, as of the Release Effective Date, against the Released Parties, pursuant to the Age Discrimination in Employment Act, as amended (which is the federal statute which makes it illegal for an employer to discharge or otherwise discriminate against an employee because of the employee’s age), including any possible claims relating to termination of your employment.

It is the specific intent and purpose of this Release to release and discharge any and all claims and causes of action of any kind or nature whatsoever as aforesaid to the full extent such release is allowed by law, from the beginning of time until the present day, whether such claims and causes of action are known or unknown and whether specifically mentioned or not. You acknowledge that you are aware that statutes exist that render null and void releases and discharges of claims and causes of actions that are unknown to the releasing or discharging party


C-1

at the time of execution of the release and discharge. You hereby expressly waive, surrender and agree to forego any protection to which you would otherwise be entitled by virtue of the existence of any such statute in any jurisdiction, including, but not limited to, the State of Maine.

You agree not only to release and discharge the Released Parties from any and all claims against the Released Parties that you could make on your own behalf, but also those which may have been or may be made by any other person or organization on your behalf.

You specifically waive any right to become, and promise not to become, a party to any case or proceeding or a member of any class in a case or proceeding in which any claim or claims are asserted against the Released Parties involving any event which has occurred as of the Date of Termination. If you are asserted to be a member of a class in a case or proceeding against the Released Parties involving any events occurring prior to or as of the Release Effective Date, you shall immediately withdraw with prejudice in writing from said class, if permitted by law to do so. You agree that this Release is, will constitute and may be pleaded as a bar to any such case or proceeding.

2.Exceptions to the Release. Notwithstanding the Release set forth above in Paragraph 1, this Release is not a waiver by you of (1) any right or claim that may arise after the Release Effective Date, (2) any right or claim to unemployment compensation, (3) any vested retirement and profit sharing benefits for which you are eligible in accordance with the terms of the respective employee benefit plans, (4) your right to indemnification from the Company under the certificate of incorporation or bylaws of the Company and in accordance with applicable law,

(4) the Accrued Obligations, (5) any rights you may have as a holder of Company common stock or equity-based incentive awards, or (6) any rights under to severance payments or benefits, as applicable, under Section 4(a) or 5(c) of the Employment Agreement, as applicable, or that may not be released by law. This is also not a waiver of any claim you may have for workers’ compensation benefits although you hereby represent to IDEXX that you do not know of any such claims and that you do not believe that you have any workplace injury relating to your employment with IDEXX. Further, nothing in this Release or the Employment Agreement (and any exhibits thereto) will be construed to affect the independent right and responsibility of the Equal Employment Opportunity Commission (“EEOC”) or a state or local fair employment practices agency acting as an EEOC referral agency to enforce employment discrimination laws. Signing this Release will not interfere with your right to file a charge or participate in an investigation or proceeding conducted by the EEOC or the state or local agency as long as you do not seek or accept any damages, remedies, or other relief for yourself personally, which you promise not to do, and any right to which you specifically waive. You understand that unless a court invalidates this Release, you have no right to recover damages against the Released Parties for your claims. Notwithstanding anything to the contrary contained herein, no provision of this Release or the Employment Agreement (or any exhibits thereto) shall be interpreted so as to impede you (or any other individual) from reporting possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the United States Congress, and any agency Inspector General, or making any other disclosures under the whistleblower provisions of United States federal law or regulation or receiving an award for information provided under any protected whistleblower or similar program. You do not need the prior authorization of IDEXX


C-2

to make any such reports or disclosures and you shall not be required to notify IDEXX that such reports or disclosures have been made.

3.No Admissions. Nothing contained herein shall be construed as an admission by IDEXX of any liability or unlawful conduct whatsoever. You agree and understand that the severance payments and benefits provided pursuant to Section 4(a) or 5(c) as applicable, of the Employment Agreement are provided solely in consideration of your execution of this Release and your obligations under the Ancillary Agreements, and that the payments and benefits are sufficient consideration for the Release.

4.Knowing Consent to Release. By signing below, you understand and agree that:

(a)You have the option to take a full [twenty-one (21)]/[forty-five (45)] days from [●], the date the Release was provided to you by IDEXX, within which to consider this Release before executing it. If you sign this Release sooner than [twenty-one (21)]/[forty-five (45)] days from when it was provided to you, you do so with the understanding that you could have taken the entire [twenty-one (21)]/[forty-five (45)]-day period to review this Release.

(b)You have carefully read and fully understand all of the provisions of this

Release.

(c)You are, through this Release, releasing the Released Parties from any and

all claims you may have against the Released Parties.

(d)You knowingly and voluntarily agree to all of the terms set forth in this

Release.

(e)You knowingly and voluntarily intend to be legally bound by the same.

(f)You have been advised in writing to consider the terms of this Release and

consult with an attorney of your choice prior to executing this Release.

(g)You acknowledge that the consideration set forth in the Section 4(a) or 5(c), as applicable, of the Employment Agreement is above and beyond anything you might otherwise be entitled to receive.

(h)You have a full seven (7) days after executing this Release to revoke this Release by delivering written notice of revocation to the Company’s Chief Human Resources Officer, and are hereby advised in writing that this Release shall not become effective or enforceable until the revocation period has expired. If the Release is not revoked, it shall become effective and irrevocable on the day next following the day on which the foregoing revocation period has expired (the “Release Effective Date”). In case of revocation, the obligations of each party to this Release shall become null and void.

5.Choice of Law. This Release shall be governed by and construed in accordance with the laws of the State of Maine. You agree and consent to submit to personal jurisdiction in the State of Maine in any state or federal court of competent subject matter jurisdiction situated in Cumberland County, Maine. You further agree that the sole and exclusive venue for any suit arising out of, or seeking to enforce, the terms of this Release and the Employment Agreement


C-3

(including all exhibits thereto) shall be in a state or federal court of competent subject matter jurisdiction situated in Cumberland County, Maine. In addition, you waive any right to challenge in another court any judgment entered by such Cumberland County court or to assert that any action instituted by IDEXX in any such court is in the improper venue or should be transferred to a more convenient forum. In addition, you and IDEXX also waive any right you or it may otherwise have to a trial by jury in any action to enforce the terms of this Release.

6.Miscellaneous.

(a)No delay or omission by IDEXX in exercising any right under this Release shall operate as a waiver of that or any other right. A waiver or consent given by IDEXX on any one occasion shall be effective only in that instance and shall not be construed as a bar or waiver of any right on any other occasion.

(b)The captions of the sections of this Release are for convenience of reference only and in no way define, limit or affect the scope or substance of any section of this Release.

(c)In case any provision of this Release shall be invalid, illegal or otherwise unenforceable, the validity, legality and enforceability of the remaining provisions shall in no way be affected or impaired thereby.

(d)Nothing in this Release precludes you from providing truthful testimony when lawfully subpoenaed or otherwise required to do so by law.

(e)By signing this Release, you hereby represent that to the best of your knowledge you did not commit any act, or fail to commit any act, or do anything else while employed by IDEXX that was a breach of your duty of loyalty (including but not limited to taking any property that belongs to IDEXX or its customers) or that might result in liability to IDEXX.

(f)This Release may not be altered, amended or modified except in writing signed by both IDEXX and you.

(g)If any provision of this Release shall be found by a court of competent jurisdiction to be invalid or unenforceable, in whole or in part, then such provision shall be construed and/or modified or restricted to the extent and in the manner necessary to render the same valid and enforceable, or shall be deemed excised from this Release, as the case may require, and this Release shall be construed and enforced to the maximum extent permitted by law, as if such provision had been originally incorporated herein as so modified or restricted, or as if such provision had not been originally incorporated herein, as the case may be. The parties further agree to seek a lawful substitute for any provision found to be unlawful; provided, that, if the parties are unable to agree upon a lawful substitute, the parties desire and request that a court or other authority called upon to decide the enforceability of this Release modify this Release so that, once modified, this Release will be enforceable to the maximum extent permitted by the law in existence at the time of the requested enforcement.

7.Complete Agreement. This Release and the Employment Agreement (and all exhibits thereto) constitute the complete understanding between you and IDEXX with respect to


C-4

your separation from employment, and this Release supersedes all prior representations, agreements, and understandings, both written and oral, between you and IDEXX with respect to the subject matters hereof.

8.Counterparts. This Release may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. Signatures delivered in .pdf format shall be deemed effective for all purposes.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]


C-5

Please sign and return a complete copy of this Release to the Company’s Chief Human Resources Officer, indicating your agreement to all of the terms of the Release. This Release shall expire if not signed by you and returned to the Company’s Chief Human Resources Officer by no later than the close of business on [●].

IDEXX

____________________________________________________________________________________________

By: Date:

Title:

You have been advised that at least [twenty-one (21)] calendar days will be provided for the review of this Release, and to consult with an attorney prior to the execution of this Release.

You represent and agree that you have carefully read and fully understand all of the provisions of this Release and that you have voluntarily entered into this Release.

Accepted and Agreed To:

___________________________________________________________________________________________

Jonathan (Jay) Mazelsky Date:

________________________________________________________________________________________________


C-6

Exhibit D

Section 280G

This Exhibit D sets forth the terms and provisions applicable to the Executive as referenced in Section 12 of the agreement to which this Exhibit D is attached (the “Agreement”). This Exhibit D shall be subject in all respects to the terms and conditions of the Agreement. All capitalized terms that are used but not defined in this Exhibit D shall have the meanings ascribed to such terms in the Agreement.

(a) If the Executive would otherwise be eligible to receive a payment or benefit pursuant to the terms of the Agreement or any equity or equity-based compensation or other agreement with the Company or any subsidiary or otherwise in connection with, or arising out of, the Executive’s employment with the Company or any subsidiary or a change in ownership or effective control of the Company or of a substantial portion of its assets (any such payment or benefit, a “Parachute Payment”), that a nationally recognized United States public accounting firm selected by the Company (the “Accounting Firm”) determines, but for this sentence, would be subject to excise tax imposed by Section 4999 of the Code (the “Excise Tax”), subject to clause (c) below, then the Company shall pay to the Executive whichever of the following two alternative forms of payment would result in the Executive’s receipt, on an after-tax basis, of the greater amount of the Parachute Payment notwithstanding that all or some portion of the Parachute Payment may be subject to the Excise Tax: (1) payment in full of the entire amount of the Parachute Payment, or (2) payment of only a part of the Parachute Payment so that the Executive receives the largest payment possible without the imposition of the Excise Tax.

(b) If a reduction in the Parachute Payment is necessary pursuant to clause (a), then the reduction shall occur in the following order: (1) reduction of cash payments (with such reduction being applied to the payments in the reverse order in which they would otherwise be made, that is, later payments shall be reduced before earlier payments) and (2) cancellation of acceleration of vesting of equity or equity-based awards; provided, that to the extent permitted by Section 409A and Sections 280G and 4999 of the Code, if a different reduction procedure would be permitted without violating Section 409A or losing the benefit of the reduction under Sections 280G and 4999 of the Code, the Executive may designate a different order of reduction.

(c) For purposes of determining whether any of the Parachute Payments (collectively, the “Total Payments”) will be subject to the Excise Tax and the amount of such Excise Tax, (i) the Total Payments shall be treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all “parachute payments” in excess of the “base amount” (as defined under Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that, in the opinion of the Accounting Firm, such Total Payments (in whole or in part): (1) do not constitute “parachute payments,” (2) represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the “base amount,” or (3) are otherwise not subject to the Excise Tax, and (ii) the value of any non- cash benefits or any deferred payment or benefit shall be determined by the Accounting Firm in accordance with the principles of Section 280G of the Code.


D-1

(d) All determinations hereunder shall be made by the Accounting Firm, which determinations shall be final and binding upon the Company and the Executive.

(e) The federal tax returns filed by the Executive (and any filing made by a consolidated tax group which includes the Company) shall be prepared and filed on a basis consistent with the determination of the Accounting Firm with respect to the Excise Tax payable by the Executive. The Executive shall make proper payment of the amount of any Excise Tax, and at the request of the Company, provide to the Company true and correct copies (with any amendments) of the Executive’s federal income tax return as filed with the Internal Revenue Service, and such other documents reasonably requested by the Company, evidencing such payment (provided, that the Executive may delete information unrelated to the Parachute Payment or the Excise Tax and provided, further, that the Company at all times shall treat such returns as confidential and use such return only for purpose contemplated by this paragraph).

(f) In the event of any controversy with the Internal Revenue Service (or other taxing authority) with regard to the Excise Tax, the Executive shall permit the Company to control issues related to the Excise Tax (at its expense). In the event that the issues are interrelated to the Excise Tax, the Executive and the Company shall cooperate in good faith so as not to jeopardize resolution of either issue. In the event of any conference with any taxing authority as to the Excise Tax or associated income taxes, the Executive shall permit a representative of the Company to accompany the Executive, and the Executive and the Executive’s representative shall cooperate in good faith with the Company and its representative.

(g) The Company shall be responsible for all charges of the Accounting Firm.

(h) The Company and the Executive shall promptly deliver to each other copies of any written communications, and summaries of any verbal communications, with any taxing authority regarding the Excise Tax covered by this Exhibit D.

(i) The provisions of this Exhibit D shall survive the termination of the Executive’s employment with the Company for any reason and the termination of the Agreement.


D-2